This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Delenex Therapeutics Ag. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Innovations of Thorsten Alexander Schäfer
Introduction
Thorsten Alexander Schäfer is a notable inventor based in Lörrach, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies.
Latest Patents
Schäfer holds a patent for an "Antibody to human IL-1 beta." This invention relates to anti-IL-1 beta binding members, specifically monovalent high potency IL-1 beta-binding antibody fragments that are highly stable and soluble. These binding members have potential applications in the treatment of inflammatory diseases and diagnostics. The patent also includes related nucleic acids, vectors, cells, and compositions.
Career Highlights
Thorsten Alexander Schäfer is associated with Delenex Therapeutics AG, a company focused on developing innovative therapeutic solutions. His work has contributed to advancements in the treatment of various diseases through the use of monoclonal antibodies.
Collaborations
Some of his notable coworkers include Stefanie Grabulovski and Titus Kretzschmar, who have collaborated with him on various projects within the company.
Conclusion
Thorsten Alexander Schäfer's innovative work in antibody development showcases his commitment to advancing medical science and improving treatment options for patients. His contributions are significant in the field of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile